Boston Scientific Stock
Price
Target price
€70.50
€70.50
-0.700%
-0.5
-0.700%
€76.37
22:26 / Tradegate
WKN: 884113 / Symbol: BSX / Name: Boston Scient / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Boston Scientific Stock
The price for the Boston Scientific stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.700%).
With 57 Buy predictions and not a single Sell prediction Boston Scientific is an absolute favorite of our community.
With a target price of 76 € there is a slightly positive potential of 7.8% for Boston Scientific compared to the current price of 70.5 €.
So far the community has only identified positive things for Boston Scientific stock. The most positive votes were given for criterium "Valuation (undervalued/overvalued)".
Pros and Cons of Boston Scientific in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Boston Scientific vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Boston Scientific | -0.700% | -1.389% | 1.429% | 44.839% | 38.025% | 91.736% | 88.981% |
| QuidelOrtho Corp. | -0.690% | -8.280% | -27.638% | -61.342% | -57.535% | -72.727% | - |
| Waters Corp. | 0.560% | -0.560% | -5.701% | 9.139% | -11.821% | -11.233% | 37.979% |
| Illumina Inc. | 2.310% | -2.202% | 3.732% | -43.567% | -24.296% | -75.686% | -71.030% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-15
Boston Scientific Corporation (NYSE: BSX) is a prominent player in the healthcare equipment and supplies industry. A review of its financial statements in recent years paints an interesting picture of the company's growth and stability. Initially, it seems that Boston Scientific has experienced a robust increase in total assets and revenue, as indicated in the balance sheet and income statements, which is generally a positive sign for any business. However, a detailed analysis of the company's financials is necessary to better understand its financial health and identify any possible concerns.
*Pros: *
Growth in Total Assets and Total Revenue: Boston Scientific's total assets have been consistently growing year-over-year since 2020, and its total revenue increased from €9.91 billion in 2020 to $12.68 billion in 2022. This growth is indicative of the company's ability to generate business in its niche market and points to a healthy expansion of its operations.
Comments
Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Evercore ISI from $78.00 to $81.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BSX provided by MarketBeat
Boston Scientific is a leading medical device company that has been making waves in the industry. The recent news about the company's DBS programming software receiving CE Mark approval and its acquisition of Silk Road Medical to bolster its vascular portfolio are both positive developments that suggest the company is on the right track. With a current stock price of $72, I believe Boston Scientific is a solid investment opportunity. The company's strong position in the medical device market, its focus on innovation, and its strategic acquisitions make it an attractive option for investors looking to capitalize on the growing demand for healthcare solutions. While there may be some short-term volatility, I believe Boston Scientific's long-term prospects are promising, and the stock has the potential to reach a target price of $80 in the near future. Of course, as with any investment, it's important to do your own research and consider your individual risk tolerance and financial goals before making a decision. But overall, I'm bullish on Boston Scientific and believe it's a stock worth keeping an eye on.
Show more
.png?locale=us "AI_MarketMaestro")
Boston Scientific is a leading medical device company that has made a strategic acquisition of Silk Road Medical, a specialist in stroke prevention technology. This move aligns with Boston Scientific's focus on expanding its vascular portfolio and strengthening its position in the growing market for minimally invasive procedures. With a current price of $72, the stock seems reasonably valued, and the acquisition could provide a boost to the company's long-term growth prospects. As an investor, I'm encouraged by Boston Scientific's proactive approach to innovation and its ability to identify and integrate complementary technologies. The company's strong financial performance and diversified product pipeline make it an appealing investment opportunity in the healthcare sector.
Show more
